175 related articles for article (PubMed ID: 28758028)
1. The interplay between genetic background and sexual dimorphism of doxorubicin-induced cardiotoxicity.
Zordoky BN; Radin MJ; Heller L; Tobias A; Matise I; Apple FS; McCune SA; Sharkey LC
Cardiooncology; 2016; 2():4. PubMed ID: 28758028
[TBL] [Abstract][Full Text] [Related]
2. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.
Sharkey LC; Radin MJ; Heller L; Rogers LK; Tobias A; Matise I; Wang Q; Apple FS; McCune SA
Toxicol Appl Pharmacol; 2013 Nov; 273(1):47-57. PubMed ID: 23993975
[TBL] [Abstract][Full Text] [Related]
3. Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice.
Grant MK; Seelig DM; Sharkey LC; Zordoky BN
Biol Sex Differ; 2017; 8():1. PubMed ID: 28078076
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats.
Aziz MM; Abd El Fattah MA; Ahmed KA; Sayed HM
Can J Physiol Pharmacol; 2020 Apr; 98(4):183-193. PubMed ID: 31665614
[TBL] [Abstract][Full Text] [Related]
5. 17β-estradiol protects against doxorubicin-induced cardiotoxicity in male Sprague-Dawley rats by regulating NADPH oxidase and apoptosis genes.
Zhang XJ; Cao XQ; Zhang CS; Zhao Z
Mol Med Rep; 2017 May; 15(5):2695-2702. PubMed ID: 28447737
[TBL] [Abstract][Full Text] [Related]
6. Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.
Potočnik N; Perše M; Cerar A; Injac R; Finderle Ž
PLoS One; 2017; 12(7):e0181632. PubMed ID: 28727839
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity.
Ibrahim MA; Ashour OM; Ibrahim YF; El-Bitar HI; Gomaa W; Abdel-Rahim SR
Pharmacol Res; 2009 Nov; 60(5):373-81. PubMed ID: 19467331
[TBL] [Abstract][Full Text] [Related]
8.
Wang Y; Chao X; Ahmad FUD; Shi H; Mehboob H; Hassan W
Cardiol Res Pract; 2019; 2019():7395239. PubMed ID: 31929900
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-induced cardiotoxicity is suppressed by estrous-staged treatment and exogenous 17β-estradiol in female tumor-bearing spontaneously hypertensive rats.
Pokrzywinski KL; Biel TG; Rosen ET; Bonanno JL; Aryal B; Mascia F; Moshkelani D; Mog S; Rao VA
Biol Sex Differ; 2018 Jun; 9(1):25. PubMed ID: 29907135
[TBL] [Abstract][Full Text] [Related]
10. Sexual dimorphism of acute doxorubicin-induced nephrotoxicity in C57Bl/6 mice.
Grant MKO; Seelig DM; Sharkey LC; Choi WSV; Abdelgawad IY; Zordoky BN
PLoS One; 2019; 14(2):e0212486. PubMed ID: 30785938
[TBL] [Abstract][Full Text] [Related]
11. Continuous electrocardiogram reveals differences in the short-term cardiotoxic response of Wistar-Kyoto and spontaneously hypertensive rats to doxorubicin.
Hazari MS; Haykal-Coates N; Winsett DW; Costa DL; Farraj AK
Toxicol Sci; 2009 Jul; 110(1):224-34. PubMed ID: 19407338
[TBL] [Abstract][Full Text] [Related]
12. Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
Lódi M; Priksz D; Fülöp GÁ; Bódi B; Gyöngyösi A; Nagy L; Kovács Á; Kertész AB; Kocsis J; Édes I; Csanádi Z; Czuriga I; Kisvárday Z; Juhász B; Lekli I; Bai P; Tóth A; Papp Z; Czuriga D
J Transl Med; 2019 Jul; 17(1):229. PubMed ID: 31324258
[TBL] [Abstract][Full Text] [Related]
13. Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity.
Ferreira A; Cunha-Oliveira T; Simões RF; Carvalho FS; Burgeiro A; Nordgren K; Wallace KB; Oliveira PJ
Toxicology; 2017 Sep; 390():63-73. PubMed ID: 28865727
[TBL] [Abstract][Full Text] [Related]
14. Effects of Calorie Restriction and Voluntary Exercise on Doxorubicin-Induced Cardiotoxicity.
Hall SE; Smuder AJ; Hayward R
Integr Cancer Ther; 2019; 18():1534735419843999. PubMed ID: 30999765
[TBL] [Abstract][Full Text] [Related]
15. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
Li M; Sala V; De Santis MC; Cimino J; Cappello P; Pianca N; Di Bona A; Margaria JP; Martini M; Lazzarini E; Pirozzi F; Rossi L; Franco I; Bornbaum J; Heger J; Rohrbach S; Perino A; Tocchetti CG; Lima BHF; Teixeira MM; Porporato PE; Schulz R; Angelini A; Sandri M; Ameri P; Sciarretta S; Lima-Júnior RCP; Mongillo M; Zaglia T; Morello F; Novelli F; Hirsch E; Ghigo A
Circulation; 2018 Aug; 138(7):696-711. PubMed ID: 29348263
[TBL] [Abstract][Full Text] [Related]
16. Acacia hydaspica R. Parker prevents doxorubicin-induced cardiac injury by attenuation of oxidative stress and structural Cardiomyocyte alterations in rats.
Afsar T; Razak S; Batoo KM; Khan MR
BMC Complement Altern Med; 2017 Dec; 17(1):554. PubMed ID: 29284479
[TBL] [Abstract][Full Text] [Related]
17. Protective Effect of Acetyl-L-Carnitine Against Doxorubicin-induced Cardiotoxicity in Wistar Albino Rats.
Dundar HA; Kiray M; Kir M; Kolatan E; Bagriyanik A; Altun Z; Aktas S; Ellidokuz H; Yilmaz O; Mutafoglu K; Olgun N
Arch Med Res; 2016 Oct; 47(7):506-514. PubMed ID: 28262191
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CACNA1H attenuates doxorubicin-induced acute cardiotoxicity by affecting endoplasmic reticulum stress.
Hu J; Wu Q; Wang Z; Hong J; Chen R; Li B; Hu Z; Hu X; Zhang M
Biomed Pharmacother; 2019 Dec; 120():109475. PubMed ID: 31580970
[TBL] [Abstract][Full Text] [Related]
19. Protective Effects of a Novel Agonist of Galanin Receptors Against Doxorubicin-Induced Cardiotoxicity in Rats.
Studneva I; Palkeeva M; Veselova O; Molokoedov A; Ovchinnikov M; Sidorova M; Pisarenko O
Cardiovasc Toxicol; 2019 Apr; 19(2):136-146. PubMed ID: 30238355
[TBL] [Abstract][Full Text] [Related]
20. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
